Breast cancer clues hint at response to therapy in animal models
The findings bring us one step closer to improving ER+ breast cancer patients’ response to therapy.
Read More
endocrine therapy
Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy
Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.
Read More